LA JOLLA, CA, April 30, 2024 – Enlaza Therapeutics, the first covalent biologic platform company, today announced a $100 million Series A financing. The financing will be used to further...
Life Sciences Summit
Event | 11. 02. 2022
Peter Young will be participating on a panel titled "Investor and Partner Insights" on November 2nd at the virtual Life Sciences Summit.
© 2024 Pappas Capital, LLC. ALL RIGHTS RESERVED.